WKN DE: A40JL1 / ISIN: KR7001062009

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

JW PHARMACEUTICAL Times and Sales (KRX)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
Times and Sales Zur Zeit stehen keine Daten zur Verfügung

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu JW PHARMACEUTICAL CORP Pfd Shs Non-Voting

Weitere Meldungen

02:39		Iconic German musician Udo Lindenberg turns 80
02:39		German intelligence offices snub US-based Palantir software
02:39		'FIFA got greedy' ― Why football fans in India may not be able to watch World Cup games on TV this year
02:35		Sport helping displaced Lebanese living in stadium to cope
02:35		Why men are less worried than women about climate change
02:35		Celebrated broadcaster and naturalist David Attenborough turns 100
02:35		Why is Hollywood missing from Cannes?
02:35		Hantavirus: How is the outbreak being contained?
02:35		Hotter 2026 and El Nino could trigger extreme fires
02:35		World Cup 'prices will drop' but too late for traveling fans
02:35		Somali piracy disrupts global shipping and trade routes
02:35		COVID pioneer BioNTech: The fall of Germany's pandemic hero
02:35		Architecture of remembrance and hope: Daniel Libeskind at 80
02:35		What the Strait of Hormuz fuel crisis means for air travel
02:35		Eurovision 2026: Politics collide with a blockbuster show
02:35		Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics?
02:32		Stocks to watch: Sats, FLCT, Boustead Singapore
02:31		Extreme weather and green energy on the rise in Europe
02:31		Gender investment gap: Are women catching up with men?
02:31		Why Saudi Arabia is withdrawing from sport
02:31		Dubai's image as a financial hub faces its biggest test yet
02:31		Iran's Vafaei playing for more than snooker glory
02:31		The sea that is vanishing in real time
02:15		JPMorgan Chase Says It Is Comfortable With $50 Billion in Private Credit Exposure. Should Investors Be?
02:00		Engie Factory Asia-Pacific acquired by Australasian venture capital firm Pacific Channel
02:00		Engie Factory Asia-Pacific acquired by New Zealand venture capital firm Pacific Channel
02:00		Don't Buy Viking Therapeutics Stock Until You Read This
01:45		If You Invested $1000 In Targa Resources Stock 5 Years Ago, You Would Have This Much Today
01:30		If You Invested $100 In Williams Companies Stock 5 Years Ago, You Would Have This Much Today
01:30		Recursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now?
01:30		Is Nvidia the Most Underrated Dividend Growth Stock to Own?
01:15		If You Invested $100 In Vertex Pharmaceuticals Stock 20 Years Ago, You Would Have This Much Today
01:15		Eli Lilly Just Got a Huge Vote of Confidence From Morgan Stanley -- and It's All About Mounjaro
01:01		China’s change in maths on carbon emissions masks growth, report says
01:00		If You Invested $1000 In Welltower Stock 15 Years Ago, You Would Have This Much Today
01:00		Karooooo: A Strong Contender in Fleet Management with Room to Grow
01:00		Why Microsoft's Split With OpenAI May Be Great for the Stock in the Long Run
00:59		Aramco to transfer PRefChem stakes to Malaysia’s Petronas
00:48		The 'Next Nvidia' Trade? Why Investors Are Suddenly Watching Advanced Micro Devices, Arm Holdings, and Marvell Technology
00:45		If You Invested $1000 In Rollins Stock 20 Years Ago, You Would Have This Much Today
00:30		Is the Palantir Valuation Debate Over? Why Some Analysts See 86% Upside in the Agentic AI Era.
00:15		$1000 Invested In Intercontinental Exchange 15 Years Ago Would Be Worth This Much Today
00:15		After the Sell-Off, Here Are the 3 Best S&P 500 Stocks to Buy Now
00:00		Here's How Much You Would Have Made Owning Waste Connections Stock In The Last 15 Years
00:00		The 3-Stock Custom Silicon Basket That Could Outperform Nvidia by 2030
25.05.26		Here's How Much $100 Invested In Curtiss-Wright 10 Years Ago Would Be Worth Today
25.05.26		$1000 Invested In Moodys 20 Years Ago Would Be Worth This Much Today
25.05.26		Ride-Share Drivers in Massachusetts Formally Unionize
25.05.26		Here's How Much $1000 Invested In Vulcan Materials 15 Years Ago Would Be Worth Today
25.05.26		Discover Credit Cards Are About to Become Capital One Cards. Why That Could Be a Bigger Deal Than Investors Think.

Zurück | 1 | 2 | 3 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: Shin Young Securities AMOREPACIFIC Group Samyang Genex Seoul Foods SamKwangGlass

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 80% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	26.05.2026 07:46
Kaufwert:	EUR
	Hinzufügen Speichern

JW PHARMACEUTICAL Aktie

WKN DE: A40JL1 / ISIN: KR7001062009

JW PHARMACEUTICAL Times and Sales (KRX)

Times and Sales

Analysen zu JW PHARMACEUTICAL CORP Pfd Shs Non-Voting

Weitere Meldungen